Comparisons

Ro vs Ozari for GLP-1 Treatment: An Honest Comparison

If you're researching GLP-1 medications for weight loss, you've likely come across both Ro and Ozari. Both companies offer telehealth access to semaglutide and tirzepatide, the active ingredients in medications that have transformed weight management. But when you're making a decision that affects your health and your budget, the details matter. Let's break down how these two options compare so you can make the choice that's right for you.

What Both Ro and Ozari Offer

Before diving into differences, it's worth noting what these platforms have in common. Both Ro and Ozari provide telehealth access to GLP-1 medications, meaning you can consult with licensed physicians online and have your medication shipped directly to your home.

Both platforms offer compounded versions of semaglutide and tirzepatide. These are FDA-regulated medications prepared by licensed compounding pharmacies, which has made GLP-1 treatment more accessible during ongoing shortages of brand-name options.

You'll get medical oversight with either choice. Real physicians review your health history, determine if you're a candidate for treatment, and provide ongoing monitoring. This isn't about buying medication online without supervision—it's legitimate medical care delivered through a modern, convenient format.

The Cost Difference: Where Ozari and Ro Diverge

This is often the first question people ask, and for good reason. GLP-1 medications represent a significant monthly investment.

Ro's pricing varies based on the specific medication and dosage, but generally starts around $145 per month for their compounded options. Some patients report costs ranging up to $300 or more monthly depending on their prescribed dose and medication type.

Ozari takes a straightforward approach with a flat $99 per month for compounded semaglutide or tirzepatide. This includes your medication, physician oversight, and shipping. There aren't surprise price increases as you move to higher doses during your treatment journey.

For many people, especially those paying out of pocket without insurance coverage, that difference of $50 to $200 monthly adds up to $600 to $2,400 annually. That's a meaningful consideration for sustainable, long-term treatment.

Treatment Approach and Physician Access

Both platforms connect you with licensed physicians, but the experience differs somewhat.

Ro's Model

Ro offers a comprehensive digital health platform that extends beyond weight management. You'll complete an online assessment, and a physician from their network will review your information. The platform is polished and tech-forward, with a broad range of health services beyond GLP-1 treatment.

Ozari's Model

Ozari focuses specifically on metabolic health and GLP-1 therapy. The physicians on the Ozari clinical team specialize in weight management and understand the nuances of these medications. This focused approach means your care team lives and breathes GLP-1 treatment daily.

Both provide asynchronous communication with your care team, meaning you can message with questions and receive responses without needing to schedule real-time appointments for routine concerns.

Medication Quality and Sourcing

This is a critical consideration. Both Ro and Ozari use compounded medications prepared by licensed U.S. pharmacies that follow FDA regulations and meet safety standards.

Compounded GLP-1 medications contain the same active ingredients as brand-name versions—semaglutide or tirzepatide—but are prepared individually by specialized pharmacies. The FDA has stated that compounding is appropriate during drug shortages, which has been the case for these medications.

Neither company is cutting corners here. You're receiving legitimate medication prepared according to proper pharmaceutical standards with either choice.

Getting Started: The Onboarding Experience

The initial process is similar with both platforms. You'll answer detailed questions about your medical history, current health status, weight loss goals, and any medications you're taking.

Ro's platform is highly streamlined and minimalist. You move through screens answering questions, and the interface feels like a modern app experience.

Ozari's process is equally straightforward but with slightly more educational content woven in. You'll learn about what to expect from treatment as you complete your assessment.

Both typically provide a decision within 24-48 hours about whether you're approved for treatment. If approved, your medication ships quickly, usually arriving within a few days.

Ongoing Support and Education

Starting medication is just the beginning. How do these platforms support you throughout your journey?

Ro provides access to their care team for questions and concerns. You can message through their platform and receive guidance on side effects, dosage adjustments, and general questions.

Ozari similarly offers care team access, with physicians and support staff who can address concerns. The focused specialization in GLP-1 treatment means you're working with a team that handles these specific questions constantly.

Both platforms will adjust your dosage over time as appropriate, following the standard titration protocols for these medications.

A Note on Gender Differences

While GLP-1 medications work similarly for all patients regardless of gender, women—particularly those in perimenopause or menopause—may experience different patterns of weight loss and side effects due to hormonal fluctuations. Some women find that their response to the medication varies with their menstrual cycle.

Men typically have higher starting metabolic rates and may see faster initial weight loss, though this evens out over time. Neither Ro nor Ozari specifically tailors treatment based on gender, but your physician should consider your complete hormonal and metabolic picture regardless of which platform you choose.

Which Option Is Right for You?

The honest answer depends on your priorities.

If you value the lowest possible monthly cost and want a team specialized specifically in GLP-1 treatment, Ozari's focused approach and $99 monthly fee make it compelling. The predictable pricing removes uncertainty from a treatment that typically lasts many months.

If you're already using Ro for other health services or prefer a platform with a broader range of offerings, staying within one ecosystem might appeal to you, even at a higher price point.

Both are legitimate options providing real medical care. Neither is a scam or shortcut. You're getting physician oversight and quality medication with either choice.

From the Ozari Care Team

Many patients ask us whether they should switch providers to save money. Our perspective: consistency in care matters, but so does sustainability. If cost is preventing you from continuing treatment long-term, switching to a more affordable option isn't just financially smart—it's medically smart, because the greatest results come from staying on treatment consistently over time.

Ready to Start Your GLP-1 Journey?

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026